title: New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary.
authors.affiliation: Department of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Angelika.BischofDelaloye@chuv.ch
authors.forename: Angelika
authors.initials: A
authors.lastname: Bischof Delaloye
authors.forename: Peter S
authors.initials: PS
authors.lastname: Conti
authors.forename: Christian
authors.initials: C
authors.lastname: Gisselbrecht
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Gregory
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy*; D016499:Radioimmunotherapy / Q000379:methods*; D016896:Treatment Outcome; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan